BIO-Y A/S: Financial statements 2017
CVR: 25507800
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
BIO-Y A/S (CVR 25507800) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -375,875 and a net result of DKK -337,090 compared with DKK -44,788 the year before. Equity in the 2017 report amounted to DKK 2,341,221. The solvency ratio was 24.4%.
- Gross Profit
- DKK -375,875
- Profit/Loss
- DKK -337,090
- Equity
- DKK 2,341,221
- Total Assets
- DKK 9,577,549
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -376 t. | -337 t. | 2.3 mio. | - |
| 2016 | - | -187 t. | -45 t. | 1.5 mio. | - |
| 2015 | - | -80 t. | -79 t. | 1.6 mio. | - |
| 2014 | - | - | -140 t. | 1.7 mio. | - |
| 2013 | - | - | 29 t. | 1.8 mio. | - |
Official annual report
Keep an eye on BIO-Y A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of September 15, 2017, Geoffrey Llewellyn Carter has joined the board of directors of BIO-Y A/S.
As of September 14, 2017, Geoffrey Llewellyn Carter has left the board of directors of BIO-Y A/S.
As of September 12, 2017, Jens Schaumann has joined the board of directors of BIO-Y A/S.
As of September 12, 2017, Anker Ernst Kreiels Ekelund has joined the board of directors of BIO-Y A/S.
As of September 12, 2017, Peter Minor has left the board of directors of BIO-Y A/S.
As of September 12, 2017, Ole Frands Sigetty has left the board of directors of BIO-Y A/S.
As of September 12, 2017, Anker Ernst Kreiels Ekelund has stepped down as director of BIO-Y A/S.
BIO-Y A/S has published its annual report for 2016. Gross profit came to DKK -187,350, and the net result was DKK -44,788.
As of March 24, 2017, Peter Minor is registered as director of BIO-Y A/S.
As of February 22, 2017, Daniel Bøøk Bonnichsen has joined the board of directors of BIO-Y A/S.
About BIO-Y A/S
BIO-Y A/S is a Danish company of the type Aktieselskab based in Helsingør, founded in 2000. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GENOMICS A/S and SCSK 3327 A/S. The company is owned by Holdingselskabet af 26. oktober 2023 ApS and Hamlet Investments Limited. The company has 1 employee (2026). In 2024, the company reported a gross profit of DKK -43,680 and a net result of DKK -1,013,053 compared with DKK -782,767 the year before. Equity in the 2024 report amounted to DKK -3,717,025.